SLU-PP-332 (500mcg) / 5-Amino-1MQ (50mg) / BPC-157 (125mcg) Tri-Compound Oral Research Formulation x 90 Tablets Oral solid-form research compound formulated for controlled analytical and investigational applications
This compound has not been evaluated by the FDA, and it should not be used to diagnose, treat, cure, or prevent any disease.
acknowledges support from the NIH (T32GM142606)
Some clinical trials suggest a neutral effect on arrhythmia risk, indicating that these medications neither significantly increase nor decrease the likelihood of atrial fibrillation
However, while it is generally safe for most people, if you experience side effects, are on medication, or have other health conditions, be sure to talk to your doctor
Despite being a dynamic process, the cellular and biophysical bases of NETosis are not well understood